Targeting the mTOR pathway in Chromophobe Kidney Cancer

Chromophobe kidney cancer accounts for approximately 5% of cases of renal cell carcinoma (RCC). While the genetics of clear cell RCC has been a major focus of research, little is known about the biology of chromophobe tumors. There is ample preclinical rationale for the use of targeted therapy in cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuch, Brian, Vourganti, Srinivas, Friend, Julia C., Zehngebot, Lee M., Linehan, W. Marston, Srinivasan, Ramaprasad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319981/
https://www.ncbi.nlm.nih.gov/pubmed/22481981
http://dx.doi.org/10.7150/jca.4378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319981/
https://www.ncbi.nlm.nih.gov/pubmed/22481981
http://dx.doi.org/10.7150/jca.4378

Ejemplares similares